Israel develops self-assembly multi-drug nanoparticles for cancer treatment: study

JERUSALEM, Aug. 29 (Xinhua) -- Israeli researchers have developed a cancer treatment using multi-drug nanoparticles by applying biological, chemical, and artificial intelligence (AI) technologies, the Israel Institute of Technology said in a statement on Tuesday.

Their study, published in the Journal of Controlled Release, is based on treatments that combine several cancer drugs. Such combinations create an effect that exceeds the cumulative benefit of the drugs.